Blue Spark Technologies, Inc.

Blue Spark Technologies, Inc. focuses on developing advanced continuous vital sign monitoring solutions to enhance patient care and streamline clinical trial data collection across healthcare settings. Founded in 2003 and headquartered in Westlake, US, Blue Spark Technologies, Inc. specializes in innovative healthcare technology aimed at vital sign monitoring.

The company has completed a total of 8 deals, with the most recent funding round occurring on November 28, 2023. The organization was founded by Daniel Gardopee, who has a history of founding other ventures in the technology sector. In this latest round, Blue Spark Technologies secured USD 3. 7 million in venture funding, marking the total amount raised to USD 3.

7 million. Blue Spark Technologies specializes in continuous vital sign monitoring solutions that enhance patient care and facilitate clinical trial data collection. Their flagship products, TempTraq™ and VitalTraq™, utilize advanced wearable technology to monitor vital signs including body temperature and heart rate, delivering real-time data to healthcare professionals. These solutions are targeted primarily towards hospitals, clinical research organizations, and healthcare providers in the United States and selected international markets, aiming to revolutionize the monitoring and recording of vital signs.

Blue Spark Technologies generates revenue through direct sales and partnerships with healthcare institutions and clinical research organizations. The company employs a subscription-based pricing model for ongoing access to its monitoring platforms, which integrate seamlessly into patient care workflows. Products like TempTraq™ and VitalTraq™ serve as essential tools for healthcare providers, enhancing monitoring capabilities and fostering partnerships with hospitals and research entities. In November 2023, Blue Spark Technologies, Inc.

raised USD 3. 7 million in venture funding from unspecified investors, part of a larger USD 5 million equity funding round. The company plans to utilize this funding to develop new products and expand into additional geographic markets. Specific regions targeted for expansion include international markets that have yet to be disclosed.

The company is focused on releasing innovative monitoring solutions to further enhance its offerings in the healthcare technology sector.